2024 witnessed a 47% increase in international patients
Riyadh
The Oncology Centre of Excellence at King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to redefine cancer care, attracting international patients and positioning itself as a premier destination for medical tourism in the GCC.
In 2024, KFSHRC achieved a 47.39% year-on-year increase in international patients, notable increases in new patient acceptance rates, outpatient visits across multiple locations and treatments administered. This growth reflects the hospital’s ability to meet the needs of an expanding patient base, deliver exceptional care, and be committed to making advanced care treatments more accessible, all in line with its vision to be the preferred choice for international cancer care.
Building on this momentum, KFSHRC’s CAR T-cell therapy program saw a 15.25% growth in 2024, underscoring its commitment to delivering life-saving, personalised treatments while improving accessibility and efficiency. In 2023, KFSHRC pioneered localised CAR T-cell production in the GCC, marking a milestone in advanced cancer therapies. Through these advancements, KFSHRC’s Oncology Centre integrates precision diagnostics, multidisciplinary expertise, and patient-centred care, aligning with national healthcare transformation goals to enhance Saudi Arabia’s global standing in healthcare and medical tourism.
As part of Arab Health 2025, a premier regional and global healthcare collaboration platform, KFSHRC shares its vision for advancing cancer care across the GCC. The event fosters discussions on cancer care progress in the region, highlighting the role of institutions such as KFSHRC in spearheading innovation and their increasing prominence as a trusted destination for international patients.
By combining innovation, expanded capacity, and compassionate care, the KFSHRC Oncology Centre remains a beacon of hope, ensuring that every patient receives exceptional treatment and support on their journey to recovery. King Faisal Specialist Hospital and Research Centre is a 2443-bed tertiary/quaternary care hospital with facilities in Riyadh, Jeddah, and Madinah in the Kingdom of Saudi Arabia. It has over 17,000 employees from over 63 nationalities. KFSHRC specialises in inpatient and outpatient medical care, with excellent centres in Oncology, Organ Transplantation, Cardiovascular Diseases, Neurosciences, and Genetic Diseases. It is recognised and ranked globally as one of the top hospitals, as on Newsweek’s and Brand Finance’s World’s Best Hospitals—Top 250 lists. KFSHRC’s International Services adhere to the highest global standards, reflected in the performance of 5K+ bone marrow and 4K+ solid organ transplants, 3K+ robotic-assisted procedures, 2K+ submitted cardiovascular inpatients annually, and much more.
